An insightful account of the pending prosecution under the Espionage Act of former National Security Agency official Thomas A. Drake appears this week in The New Yorker. Author Jane Mayer delves deeply into the origins of the case stemming from Drake’s critical view of NSA management and surveillance practices. She explores the unfolding consequences of the case and its larger significance.
Among the article’s many striking observations on the Drake case is the concluding quote from Mark Klein, a former AT&T employee who exposed warrantless surveillance activity by the Bush Administration. “I think it’s outrageous,” he says. “The Bush people have been let off. The telecom companies got immunity. The only people Obama has prosecuted are the whistle-blowers.”
See “The Secret Sharer” by Jane Mayer, The New Yorker, May 23, 2011.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.